Non-invasive diagnosis of non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and / or liver fibrosis

摘要

The present invention relates to a non-invasive method for the diagnosis of non-alcoholic fatty liver disease, in particular non-alcoholic steatohepatitis, and / or liver fibrosis based on the level of miR-452 in a bodily fluid sample.